$IBRX I believe ImmunityBio is being ignored because they didn't sell out to Big Pharma. They don't want to be an R&D company that gets bought out. They want to change the game. Also, they don't pay for ads, so Big Media doesn't give them any airtime. Ad buying serves two purposes, shuts up the negative press, and provides an avenue for positive press. Organic growth takes time - just look at Tesla. When it crosses the inflection point it goes vertical growth https://t.co/fWscfUdjBk
View on X ↗